Biodexa Pharmaceuticals (BDRX) Inventory Average (2016 - 2018)

Biodexa Pharmaceuticals (BDRX) has 3 years of Inventory Average data on file, last reported at $1.1 million in Q4 2018.

• For the quarter ending Q4 2018, Inventory Average fell 10.45% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2018 stood at $1.1 million (down 10.45% YoY), and the FY2018 full-year result was $1.0 million, down 11.56% from the prior year.
• Inventory Average fell to $1.1 million in Q4 2018, from $1.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.3 million in Q2 2018 to a low of $913407.8 in Q2 2016.
• A 3-year average of $1.1 million and a median of $1.1 million in 2017 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average gained 19.46% in 2017 and declined 10.45% in 2018, its largest moves.
• Tracing BDRX's Inventory Average over 3 years: stood at $1.1 million in 2016, then increased by 12.58% to $1.2 million in 2017, then fell by 10.45% to $1.1 million in 2018.
• Business Quant data shows BDRX's Inventory Average at $1.1 million in Q4 2018, $1.3 million in Q2 2018, and $1.2 million in Q4 2017.